Date of Publication :20th November 2023

Abstract: Cardiovascular ailments stand as prominent causes of mortality worldwide, with atherosclerosis being a primary contributor to heart attacks. Key risk factors encompass hyperlipidemia, obesity, smoking, and hypertension. In addressing dyslipidemia, a pivotal interventional approach involves the utilization of lipid-lowering medications. These drugs should be uncomplicated for prolonged use. Alongside pharmaceuticals, various plant-based compounds are recognized for their potential in reducing cardiovascular risks. Epidemiological research underscores a direct correlation between heightened consumption of vegetables and antioxidant-rich foods and a diminished risk of cardiovascular maladies. The method to prepare an aqueous extract of okra plant mucilage entails blending one kilogram of okra skin with one liter of water, allowing it to stand for 5-6 hours, followed by a half-hour boil. The resultant mixture is then strained after an additional 5-6 hours to obtain the aqueous extract of okra plant mucilage. For the production of okra capsules, the extracted mucilage undergoes drying in an oven at 40℃. Subsequently, it is sieved in a desiccator maintained at 30℃ and 45% humidity. This dried extract, comprising 450gr, is combined with 20gr of microcrystalline cellulose, 500gr of cross povidone, 90gr of sodium lauryl sulfate, and 90gr of talc. The resulting mixture is employed to create the desired capsules

Reference :